Evonik Industries Past Earnings Performance
Past criteria checks 0/6
Evonik Industries's earnings have been declining at an average annual rate of -24.2%, while the Chemicals industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 7.3% per year.
Key information
-24.2%
Earnings growth rate
-24.1%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 7.3% |
| Return on equity | -5.0% |
| Net Margin | -3.0% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Evonik Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 15,267 | -465 | 2,316 | 433 |
| 30 Sep 23 | 16,002 | -604 | 2,371 | 455 |
| 30 Jun 23 | 17,109 | -295 | 2,514 | 455 |
| 31 Mar 23 | 17,995 | 272 | 2,560 | 461 |
| 31 Dec 22 | 18,488 | 539 | 2,566 | 460 |
| 30 Sep 22 | 18,238 | 926 | 2,561 | 471 |
| 30 Jun 22 | 17,231 | 944 | 2,457 | 474 |
| 31 Mar 22 | 16,095 | 869 | 2,348 | 472 |
| 31 Dec 21 | 14,955 | 748 | 2,253 | 464 |
| 30 Sep 21 | 14,078 | 724 | 2,186 | 449 |
| 30 Jun 21 | 13,124 | 642 | 2,068 | 435 |
| 31 Mar 21 | 12,314 | 546 | 2,030 | 428 |
| 31 Dec 20 | 12,199 | 489 | 2,022 | 433 |
| 30 Sep 20 | 12,270 | 614 | 2,011 | 430 |
| 30 Jun 20 | 12,585 | 617 | 2,045 | 433 |
| 31 Mar 20 | 13,065 | 679 | 2,070 | 430 |
| 31 Dec 19 | 13,108 | 753 | 2,079 | 428 |
| 30 Sep 19 | 13,084 | 506 | 2,111 | 437 |
| 30 Jun 19 | 13,199 | 624 | 2,139 | 435 |
| 31 Mar 19 | 13,306 | 673 | 2,163 | 443 |
| 31 Dec 18 | 13,267 | 686 | 2,162 | 437 |
| 30 Sep 18 | 13,580 | 841 | 2,238 | 446 |
| 30 Jun 18 | 13,789 | 797 | 2,293 | 457 |
| 31 Mar 18 | 13,994 | 788 | 2,353 | 467 |
| 31 Dec 17 | 14,383 | 713 | 2,409 | 476 |
| 30 Sep 17 | 14,015 | 723 | 2,365 | 462 |
| 30 Jun 17 | 13,623 | 718 | 2,321 | 455 |
| 31 Mar 17 | 13,262 | 656 | 2,273 | 445 |
| 31 Dec 16 | 12,732 | 748 | 2,201 | 438 |
| 30 Sep 16 | 12,725 | 758 | 2,180 | 448 |
| 30 Jun 16 | 12,926 | 725 | 2,154 | 441 |
| 31 Mar 16 | 13,188 | 981 | 2,150 | 436 |
| 31 Dec 15 | 13,507 | 1,008 | 2,140 | 434 |
| 30 Sep 15 | 13,535 | 1,027 | 2,176 | 416 |
| 30 Jun 15 | 13,413 | 1,004 | 2,131 | 416 |
| 31 Mar 15 | 13,141 | 695 | 2,045 | 416 |
| 31 Dec 14 | 12,917 | 577 | 2,010 | 413 |
| 30 Sep 14 | 12,780 | 471 | 2,021 | 411 |
| 30 Jun 14 | 12,735 | 444 | 2,026 | 408 |
| 31 Mar 14 | 12,697 | 489 | 2,060 | 400 |
| 31 Dec 13 | 12,708 | 626 | 2,064 | 394 |
| 30 Sep 13 | 12,798 | 837 | 2,097 | 396 |
| 30 Jun 13 | 12,959 | 1,040 | 2,104 | 391 |
Quality Earnings: EVKD is currently unprofitable.
Growing Profit Margin: EVKD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EVKD is unprofitable, and losses have increased over the past 5 years at a rate of 24.2% per year.
Accelerating Growth: Unable to compare EVKD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EVKD is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.4%).
Return on Equity
High ROE: EVKD has a negative Return on Equity (-5.03%), as it is currently unprofitable.